CA$100

Accelerating Innovations and Investments in Rare and Orphan Diseases

Event Information

Refund Policy

Refund Policy

Contact the organizer to request a refund.

Eventbrite's fee is nonrefundable.

Event description
Virtual Investor and Innovator Conference June 25, 2020 12pm - 5pm EST Presented by Translational Solutions, Keiretsu ForumCanada & Episome

About this Event

Translational Solutions for Healthcare ("TSHC"), Keiretsu Forum Canada and Episome Healthcare Investing and Consulting Services are joining forces to present Accelerating Innovations & Investments in Rare & Orphan Diseases. The conference will be held virtually on June 25th between 12 pm - 5pm EST.

350 million people worldwide are living with a Rare Disease, including patients diagnosed with well known illnesses such as Crohn's Disease, Multiple Myeloma and Cystic Fibrosis.

Growth in the Rare & Orphan Disease sector continues to be driven by venture, angel, social and other strategic investors, creating great deal-flow, compelling exits, and high ROIs. 

The Orphan Drug sector, in particular, is expected to grow from $130 billion to over $260 billion in 2024, at a CAGR of 11.3%, almost double that of drugs treating more common illnesses.

In addition to therapeutics, you will hear from early and later stage companies involved in drug discovery, genomics, precision medicine and AI, as well as learn from experts in the field and participate in engaging panel discussions. 

Join us virtually on June 25th for a packed schedule and exciting new investment opportunities!

Register early to reserve your virtual seat at the Deal-Flow Table! 

Share with friends

Location

Online Event

Refund Policy

Contact the organizer to request a refund.

Eventbrite's fee is nonrefundable.

Save This Event

Event Saved